(1/4)#NAPainSchool is excited to introduce the incredible group of #pain research trainees joining us in Montebello in June.🍁🎓
Throughout the program, they’re engaging in cutting-edge discussions, hands-on learning, and meaningful collaboration with pain research experts🔎
El grupo de investigación del Laboratorio BL-202, a cargo del Dr. Fatuel Tecuapetla, te invita a leer su más reciente aportación en la publicación en The Journal of Neuroscience: https://t.co/46bzudzpZw
CONVOCATORIA 2026, BECA PARA ESTANCIA CORTA EN EL EXTRANJERO - DR. JORGE ROSENKRANS
Para mayor información:
Correo electrónico: [email protected]
Página web: https://t.co/uJxoccpcFC
11 projects have been selected for MBI Spatial Transcriptomics Pilot Awards, designed to promote innovative research studies through our new Cellular and Molecular Core.
Learn more about the projects: https://t.co/8YOgrocq5S
We are thrilled to announce that two of our researchers have received awards for their poster presentations!
Congratulations to both Erick Rodriguez-Palma and Alaina Waters on this well-deserved recognition of your research excellence.
https://t.co/104bUoSyQO
A high-resolution genomic roadmap for chronic pain converges on glutamatergic neurons and C-fibers: https://t.co/8zKFaNJWHy
Erick J. Rodríguez-Palma & Rajesh Khanna @KhannaLabUF@uflorida provide a Commentary on Sylvanus Toikumo et al. (https://t.co/sfPUnK6FfF)
When Tyler Nelson suddenly went from a competitive runner to coping with recurring bouts of muscle weakness, paralysis and pain, it marked the beginning of a new way of life — and a new focus in his work as a young neuroscientist at the MBI.
Read more: https://t.co/TuLu9oJyR5
"I kept asking myself whether choosing a career in science, so far from home, had been the right decision. I felt a little like the species I study as a postdoc: the spotted lanternfly, an invasive insect that threatens U.S. ecosystems. I, too, was unwelcome and out of place." #ScienceWorkingLife https://t.co/Uy2yuWNdDT
Excited to share this short video about my project funded by @PhRMAfoundation! I’m exploring new strategies to treat fibromyalgia. Grateful for the support of @KhannaLabUF 🥼🔬
#PhF25 awardee @ErickJ_Rodrigz@UF_Pharmacology is exploring the underlying cause of #fibromyalgia, a chronic #pain condition. Specifically, he is studying the role of calcium & sodium ion channels, key players in pain signaling.
Watch the full interview: https://t.co/FU5nRBcbFa
Original: Drs. Islas-Espinoza, Granados-Soto (@cinvestav) et. coll. found that cannabidiol relieves neuropathic pain and cognitive issues in female mice via spinal PPARγ and 5-HT1A receptors.
Full: https://t.co/hP8A8OB11V
For readers interested in ion channels as drug targets, this Review in the May issue focuses on voltage-gated sodium channels, such as Nav1.8, the target of the first new non-opioid analgesic to be approved in decades
https://t.co/BWwoiM6ujX
https://t.co/PCKQMmafmK
Today is the day! Join the Pain Research & Integrated Neuroscience Center (PRINC) for their Inaugural Symposium TODAY from 9:00 AM to 5:00 PM in the HPNP Auditorium. Breakfast and lunch will be provided. See you there!
#PhF25 awardee Dr. Erick Rodriguez-Palma @UF_Pharmacology is evaluating a novel compound for the treatment of #fibromyalgia. He will study whether it reduces pain behaviors in male & female mice with fibromyalgia induced by chronic restraint stress.
https://t.co/4hEQDktyWj
This week we are featuring our 2025 #DrugDiscovery award recipients on our social media! Follow along to learn about our awardees and their research. https://t.co/OZ9wacKjIH
Acute pharmacological inhibition of PIKfyve blocks Nav1.7/1.8 sodium channels, reducing neuropathic & inflammatory pain in mice. This suggests PIKfyve as a target for novel pain therapies #painresearch#ionchannels#drugdiscovery https://t.co/Bt4kybeKPP
A compound with the potential for managing diverse pain conditions!
@KhannaLabUF@SHestehave & team @UFMedicine identify C2230 that targets Ca2+ channels & relieves neuropathic, orofacial, and osteoarthritis pain in models: https://t.co/LoXwnTbAWw